Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the one-stop shop for Big Pharma seeking mid-stage products to license or acquire.
| CEO: |
Jeremy Skillington |
| CFO: |
Ian OConnel |
| Executive Chairman: |
Cathal Friel |
| Independent Non-Executive Director: |
Edward Gibson, Luke ONeill, Brendan Buckley |
| Address: |
Queen Mary Bioenterprises Innovation Centre, 42 New Road, London, United Kingdom |
| Phone: |
+44 (0)20 7183 1499 |
| Fax: |
|
| Website: |
http://www.poolbegpharma.com/ |
| Email: |
|